Koh Iwasaki

1.8k citations
36 papers · 1.0k indexed · h-index 16
Topics
Alkaloids: synthesis and pharmacology (7 papers)Alzheimer's disease research and treatments (6 papers)Neurological Disease Mechanisms and Treatments (5 papers)
Partner nations
JapanCanadaUnited States

In The Last Decade

Koh Iwasaki

34 papers receiving 990 citations

Peers

Koh Iwasaki
Comparison fields: 5 of 100
  • Pharmacology 366
  • Complementary and alternative medicine 266
  • Physiology 249
  • Psychiatry and Mental health 175
  • Molecular Biology 162
Replace Mohammad Ali Azarbayjani with:
Mohammad Ali Azarbayjani Iran
George Thomas United States
Sang‐Kwan Moon South Korea
Xiaojia Ni China
Andréia Machado Cardoso Brazil
Guilherme Bresciani Brazil
Noriyasu Ota Japan
Catherine Buettner United States
Chuthamanee Suthisisang Thailand
Katsuya Suemaru Japan
Koh Iwasaki relative to Mohammad Ali Azarbayjani Iran Mohammad Ali Azarbayjani's profile →
Citations per field
00.5×2.8×
Mohammad Ali Azarbayjani · 1×
Citations per year

Countries citing papers authored by Koh Iwasaki

Since Specialization
Citations

This map shows the geographic impact of Koh Iwasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koh Iwasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koh Iwasaki more than expected).

Fields of papers citing papers by Koh Iwasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koh Iwasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koh Iwasaki. The network helps show where Koh Iwasaki may publish in the future.

Co-authorship network of co-authors of Koh Iwasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Koh Iwasaki. A scholar is included among the top collaborators of Koh Iwasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koh Iwasaki. Koh Iwasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 1
4 3
5 3
6 4
7 14
8 3
9 39
10 20
11 10
12 0
13 14
14 85
15 15
16 21
17 104
18 21
19 252
20 6

About Koh Iwasaki

Koh Iwasaki is a scholar working on Complementary and alternative medicine, Pharmacology and Biological Psychiatry, having authored 36 papers that have together received 1.0k indexed citations. Recurring topics across this work include Alkaloids: synthesis and pharmacology (7 papers), Alzheimer's disease research and treatments (6 papers) and Neurological Disease Mechanisms and Treatments (5 papers). The work is most often cited by research in Pharmacology (366 citations), Complementary and alternative medicine (266 citations) and Biological Psychiatry (60 citations). Koh Iwasaki has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Takashi Seki, Hiroyuki Arai, Shin Takayama, Naoki Tomita, Hironori Fujiwara, Masahiro Maruyama, Yasutake Monma, Miyako Nemoto, Haruko Tanji and Masahiko Fujii. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Neurochemistry and Journal of the American Geriatrics Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026